Tag: Gold

Finance

Sizzling Stocks: Facebook Inc (NASDAQ:FB), Frontier Communications Corporation (NASDAQ:FTR), Franklin Street Properties Corp. (NYSEMKT:FSP), Cardinal Financial Corp. (NASDAQ:CFNL), Randgold Resources Limited (NASDAQ:GOLD)

Facebook Inc (NASDAQ:FB) will announce its financial results for the fourth quarter of 2014 and the full year after market close Wednesday, Jan. 28, the social network announced Tuesday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 24.50% and weekly performance is -3.89%. On last trading day company shares ended up $76.15. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average … Continue reading Sizzling Stocks: Facebook Inc (NASDAQ:FB), Frontier Communications Corporation (NASDAQ:FTR), Franklin Street Properties Corp. (NYSEMKT:FSP), Cardinal Financial Corp. (NASDAQ:CFNL), Randgold Resources Limited (NASDAQ:GOLD)

Adam Keintzel
Finance

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists of reimbursable clinical trial, manufacturing and preclinical costs incurred by … Continue reading Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz
Finance

Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults from 10 years through 25 years of age. Novartis AG … Continue reading Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Jayne Crisman
Analysis, BioTech, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Goldcorp Incurs Elevated Cash Costs in 1Q While Increasing Production

Goldcorp GG reported disappointing first-quarter results Thursday, with considerable production growth that was met with sizable cost inflation. While the firm’s key growth projects remain on track to boost production, we believe its elevated operating expenses do not show signs of material remission. Goldcorp’s cost position rests near the middle of the industry cost curve, which is the primary reason we don’t think it enjoys … Continue reading Goldcorp Incurs Elevated Cash Costs in 1Q While Increasing Production

John MeadyLeave a comment